Basic Information
RNALocate ID: RLID:11002555
RNA Symbol: hsa-miR-382-5p
Localization: Microvesicle
RNA Information
RNA Name: hsa-miR-382
RNA ID: miRBase:MIMAT0000737
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 23539611
Tissue/Cell Line: Seminal plasma
Method: Microarray
Description: In order to assess the reversibility of post-vasectomy miRNA sequelae, we investigated whether SMV miRNAs altered by vasectomy could be retrieved in SMVs from normospermic vasovasostomized donors. miRNA microarray profiling performed on SMVs from normal, vasectomized and vasovasostomized donors identified 313 miRNAs whose intensity was above the threshold of detection. Among these miRNAs, 293 were detected in samples from normal donors, 275 in vasectomized donors and 298 in vasovasostomized donors (Fig. 3, Supplementary data, Table SIV). Data are collected from Table S4.
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01002047 Mitochondrion Skeletal muscle myoblasts 21637849
RLID:11002548 Exosome Serum 18589210
RLID:11002549 Exosome Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) 20615901
RLID:11002550 Exosome Jurkat-derived T cell line (J77cl20) 21505438
RLID:11002551 Exosome Brain tissue 23382797
RLID:11002552 Exosome Plasma 23663360
RLID:11002553 Exosome B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells 25242326
RLID:11002554 Microvesicle Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) 20615901
RLID-D:11000126 Exosome Blood
RLID-D:11000425 Microvesicle Blood|Fibroblasts|Mesenchymal stem cells|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-382-5p Pheochromocytoma MNDR-E-MI-47191
MNDR hsa-miR-382-5p Oral squamous cell carcinoma MNDR-E-MI-47192
MNDR hsa-miR-382-5p Medulloblastoma MNDR-E-MI-47193
MNDR hsa-miR-382-5p High-grade serous ovarian carcinoma MNDR-E-MI-47194
MNDR hsa-miR-382-5p Uterine corpus endometrial carcinoma MNDR-E-MI-47195
MNDR hsa-miR-382-5p Lymphoma MNDR-E-MI-47196
MNDR hsa-miR-382-5p Estrogen-receptor positive breast cancer MNDR-E-MI-47197
MNDR hsa-miR-382-5p Estrogen-receptor negative breast cancer MNDR-E-MI-47198
MNDR hsa-miR-382-5p Progesterone-receptor positive breast cancer MNDR-E-MI-47199
MNDR hsa-miR-382-5p Progesterone-receptor negative breast cancer MNDR-E-MI-47200
MNDR hsa-miR-382-5p Her2-receptor positive breast cancer MNDR-E-MI-47201
MNDR hsa-miR-382-5p Niemann-pick disease type c MNDR-E-MI-47202
MNDR hsa-miR-382-5p Dermatomyositis MNDR-E-MI-47203
MNDR hsa-miR-382-5p Gastric cancer MNDR-E-MI-47204
MNDR hsa-miR-382-5p Alzheimer disease MNDR-E-MI-47205
MNDR hsa-miR-382-5p Dysautonomia familial MNDR-E-MI-47206
MNDR hsa-miR-382-5p Muscular dystrophy duchenne MNDR-E-MI-47207
MNDR hsa-miR-382-5p Head and neck cancer MNDR-E-MI-47208
MNDR hsa-miR-382-5p Huntington disease MNDR-E-MI-47209
MNDR hsa-miR-382-5p Chorea MNDR-E-MI-47210
MNDR hsa-miR-382-5p Lung cancer MNDR-E-MI-47211
MNDR hsa-miR-382-5p Fragile x syndrome MNDR-E-MI-47212
MNDR hsa-miR-382-5p Parkinson disease MNDR-E-MI-47213
MNDR hsa-miR-382-5p Niemann-pick disease MNDR-E-MI-47214
MNDR hsa-miR-382-5p Breast cancer MNDR-E-MI-47215
MNDR hsa-miR-382-5p Squamous cell carcinoma MNDR-E-MI-47216
MNDR hsa-miR-382-5p Thyroid cancer MNDR-E-MI-47217
MNDR hsa-miR-382-5p Pituitary neoplasms MNDR-E-MI-47218
MNDR hsa-miR-382-5p Pancreatic cancer MNDR-E-MI-47219
MNDR hsa-miR-382-5p Melanoma MNDR-E-MI-47220
MNDR hsa-miR-382-5p Nephroblastoma MNDR-E-MI-47221
MNDR hsa-miR-382-5p Ischemic attack transient MNDR-E-MI-47222
MNDR hsa-miR-382-5p Colon adenocarcinoma MNDR-E-MI-47223
MNDR hsa-miR-382-5p Familial ovarian cancer MNDR-E-MI-47224
MNDR hsa-miR-382-5p Carcinoma ductal breast MNDR-E-MI-47225
MNDR hsa-miR-382-5p Glioblastoma MNDR-E-MI-47226
MNDR hsa-miR-382-5p Glioma MNDR-E-MI-47227
MNDR hsa-miR-382-5p Nemaline myopathy MNDR-E-MI-47228
MNDR hsa-miR-382-5p Chordoma MNDR-E-MI-47229
MNDR hsa-miR-382-5p Amyotrophic lateral sclerosis MNDR-E-MI-47230
MNDR hsa-miR-382-5p Osteosarcoma MNDR-E-MI-47231
MNDR hsa-miR-382-5p Meningioma MNDR-E-MI-47232
MNDR hsa-miR-382-5p Uterine cancer MNDR-E-MI-47233
MNDR hsa-miR-382-5p Gastric adenocarcinoma MNDR-E-MI-47234
MNDR hsa-miR-382-5p Bone-invasive pituitary adenoma MNDR-E-MI-47235
MNDR hsa-miR-382-5p Lung squamous cell carcinoma MNDR-E-MI-47236
MNDR hsa-miR-382-5p Lung adenocarcinoma MNDR-E-MI-47237
MNDR hsa-miR-382-5p Adrenocortical carcinoma MNDR-E-MI-47238
MNDR hsa-miR-382-5p Thyroid carcinoma MNDR-E-MI-47239
MNDR hsa-miR-382-5p Ovarian carcinoma MNDR-E-MI-47240
MNDR hsa-miR-382-5p Bladder urothelial carcinoma MNDR-E-MI-47241
MNDR hsa-miR-382-5p Pancreatic adenocarcinoma MNDR-E-MI-47242
MNDR hsa-miR-382-5p Carcinoma renal cell MNDR-E-MI-47243
MNDR hsa-miR-382-5p Kidney renal papillary cell carcinoma MNDR-E-MI-47244
MNDR hsa-miR-382-5p Clear cell renal cell carcinoma MNDR-E-MI-47245
MNDR hsa-miR-382-5p Adenocarcinoma of esophagus MNDR-E-MI-47246
MNDR hsa-miR-382-5p Esophageal cancer MNDR-E-MI-47247
MNDR hsa-miR-382-5p Prolactinoma MNDR-E-MI-47248
MNDR hsa-miR-382-5p Synovial sarcoma MNDR-E-MI-47249
MNDR hsa-miR-382-5p Head and neck squamous cell carcinoma MNDR-E-MI-47250
MNDR hsa-miR-382-5p Breast invasive carcinoma MNDR-E-MI-47251
MNDR hsa-miR-382-5p Familiar ovarian carcinoma MNDR-E-MI-47252
MNDR hsa-miR-382-5p Retinoblastoma MNDR-E-MI-47253
MNDR hsa-miR-382-5p Skin cutaneous melanoma MNDR-E-MI-47254
MNDR hsa-miR-382-5p Skin melanoma MNDR-E-MI-47255
MNDR hsa-miR-382-5p Colorectal cancer MNDR-E-MI-47256
MNDR hsa-miR-382-5p Nasopharynx carcinoma MNDR-E-MI-47257
MNDR hsa-miR-382-5p Nasopharyngeal cancer MNDR-E-MI-47258
MNDR hsa-miR-382-5p Polymyositis MNDR-E-MI-47259
MNDR hsa-miR-382-5p Cerebral hemorrhage traumatic MNDR-E-MI-47260
MNDR hsa-miR-382-5p Stroke lacunar MNDR-E-MI-47261
MNDR hsa-miR-382-5p Breast cancer her3+ negative MNDR-E-MI-47262
MNDR hsa-miR-382-5p Solid-pseudopapillary neoplasm of pancreas MNDR-E-MI-47263
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter ATXN1 Homo sapiens RR00165932
TOP